STX Shield Therapeutics

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven

Hardman & Co Research
Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven

21-Nov-2024 / 11:15 GMT/BST
The issuer is solely responsible for the content of this announcement.

Hardman & Co Investor Forum Research on Shield Therapeutics (STX):
Proactive cash management to cashflow-breakeven
 

Shield is a commercial-stage pharma company delivering specialty products that address the needs of patients with iron deficiency (ID). Since its July 2021 US launch, Shield and Viatris have increased physician awareness of the differentiating characteristics of ACCRUFeR® as an oral ID drug, in order to generate sales traction. The 3Q’24 trading update reiterated the interim statement dialog: sales continue to progress, while costs are being actively managed. Shield is being proactive, extending its working capital financing from $10m to $15m and issuing $10m new shares to AOP, to manage the company through to cashflow-breakeven in 2H’25.
 

Please click on the link below for the full report:

If you are interested in meeting the company, you can register your interest by clicking on the above link.

To contact us:

Hardman & Co

9 Bonhill Street

London

EC2A 4DJ

 

Follow us on X:

Contact:

Martin Hall


 

 



 

Hardman & Co Research can be accessed for free under MiFID. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
End of Announcement - EQS News Service

2035795  21-Nov-2024 

fncls.ssp?fn=show_t_gif&application_id=2035795&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
21/11/2024

Underlying

STXShield Therapeutics

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Shield Therapeutics

Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson
TYM Tertiary Minera...
CCT Character Group... ... (+10)

Hybridan Small Cap Feast: 01/10/2025

1st October 2025 @HybridanLLP * A corporate client of Hybridan LLP. ** Potential means Intention to Float (ITF) or similar announcement has been made. ***Arranged by type of listing and date of announcement. ****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication. Dish of the day Admissions: None Delistings: None What’s baking in the oven? Potential** Initial...

TYM TERTIARY MINERALS PLC
CCT CHARACTER GROUP PLC
STX SHIELD THERAPEUTICS
NTBR NORTHERN BEAR
TGP TEKMAR GROUP
LIT LITIGATION CAPITAL MANAGEMENT
AXL. ARROW EXPLORATION LTD
CORO CORO ENERGY PLC
AUK AUKETT SWANKE
INT INTELLEGO TECHNOLOGIES AB
10/01/25 October 1, 2025 1 EN
Hybridan Team ... (+2)
  • Hybridan Team
  • Jon Levinson
QXT QUIXANT
STX Shield Therapeu... ... (+7)

Hybridan Monthly, 1 October 2025

Hybridan Monthly, 1 October 2025 Market Comment: View from the Broker’s Desk Why you can’t compare a Defender to a Lamborghini I would always choose a Defender (90 version of course, not the Chelsea tractor new style) over a Lamborghini. Whilst many will always be taken in by the allure of brighter colours, louder engines, and slender appearance, there are some that will stay loyal to the homegrown juggernaut. It’s becoming an unfortunate common occurrence when you pick up the paper and r...

QXT QUIXANT
STX SHIELD THERAPEUTICS
ZOO ZOO DIGITAL GROUP PLC
PYC PHYSIOMICS PLC
TGP TEKMAR GROUP
SSIT SERAPHIM SPACE INVESTMENT TRUST PLC
HERC HERCULES SITE SERVICES PLC
09/30/25 September 30, 2025 1 EN
Hybridan Team
  • Hybridan Team
WPHO Windar Photonic...
DIS DISTIL ... (+9)

Hybridan Small Cap Feast: 15/09/2025

15th September 2025 @HybridanLLP * A corporate client of Hybridan LLP. ** Potential means Intention to Float (ITF) or similar announcement has been made. ***Arranged by type of listing and date of announcement. ****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication. Dish of the day Admissions: None Delistings: Henderson International Income Trust (HINT.L) left the...

WPHO WINDAR PHOTONICS
DIS DISTIL
STX SHIELD THERAPEUTICS
BGO BANGO
ING INGENTA
SFOR S4 CAPITAL
LIT LITIGATION CAPITAL MANAGEMENT
RENX RENALYTIX PLC
ITX ITACONIX PLC
09/15/25 September 15, 2025 1 EN
Hybridan Team
  • Hybridan Team
IOF IOFINA
STX Shield Therapeu... ... (+11)

Hybridan Small Cap Feast: 04/09/2025

Our daily digest of news from UK Small Caps 4th September 2025 @HybridanLLP * A corporate client of Hybridan LLP. ** Potential means Intention to Float (ITF) or similar announcement has been made. ***Arranged by type of listing and date of announcement. ****Alphabetically arranged and Closing Price on prior day to Publication. Dish of the day Admissions: Delistings: Adriatic Metals (ADT1.) has left the Main Market. What’s baki...

IOF IOFINA
STX SHIELD THERAPEUTICS
FAB FUSION ANTIBODIES
BLOE THOR MINING PLC
BKS BEEKS FINANCIAL CLOUD GROUP
ESYS ESSENSYS
AREC ARECOR THERAPEUTICS
NWT NEWMARK SECURITY PLC
BLOK BLOCK ENERGY
ECOB FOX MARBLE HOLDINGS PLC
THR THOR ENERGY PLC
09/04/25 September 4, 2025 1 EN
Hybridan Team
  • Hybridan Team
CTG Christie Group ...
PGH Personal Group ... ... (+9)

Hybridan Small Cap Feast: 23/07/2025

Dish of the day Admissions: None Delistings: Yesterday (22nd July), FD Technologies (FDP.L) left AIM

CTG CHRISTIE GROUP PLC
PGH PERSONAL GROUP HOLDINGS PLC
CASP CASPIAN SUNRISE
3IM MANX FINANCIAL GROUP PLC
STX SHIELD THERAPEUTICS
VANL VAN ELLE HOLDINGS
CYAN CYANCONNODE HOLDINGS
ITX ITACONIX PLC
MHC MYHEALTHCHECKED PLC
07/24/25 July 24, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch